To further validate the contributions of PKD3 to prostate cancer cell growth through SREBP1-mediated lipogenesis, we first investigated the effect of PKD3 and FASN on the prostate cancer cell growth by cell proliferation assay. The gene discussed is SREBF1; the disease is prostate carcinoma.